miércoles, 16 de enero de 2019

BeiGene drug gets 'breakthrough therapy' designation from FDA - MarketWatch

BeiGene drug gets 'breakthrough therapy' designation from FDA - MarketWatch

The Readout

Damian Garde

BeiGene drug gets 'breakthrough therapy' designation from FDA



By

WALLACEWITKOWSKI



REPORTER
Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)